Abstract

Lithium is a well-known medication that has been used for many years to treat mood disorders. One of its side effects is cardiotoxicity, which usually occurs at serum lithium levels > 1.5 mEq/L but rarely occurs when therapeutic levels of lithium are used. Other causes of bradycardia should be eliminated by performing a detailed workup that includes calcium level, thyroid function, and cardiac workup, with consideration of any medication interactions. Lithium-induced bradycardia is reversible upon discontinuation of lithium, but irreversible sinus node can occur and may warrant permanent insertion of a pacemaker to maintain sinus rhythm when long-term lithium therapy is required. Herein, we describe the case of a 42-year-old woman who presented with symptomatic bradycardia. Bipolar disorder was described in her past medical history, and she was receiving lithium therapy. A detailed workup indicated bradycardia secondary to lithium use. Her condition improved after discontinuation of the lithium, and normal sinus rhythm was restored over the next three days.

Highlights

  • Lithium is efficacious for treating psychiatric illness, including mania and major depression associated with bipolar illness

  • The use of lithium at therapeutic and toxic serum levels is associated with major cardiovascular side effects, including sinus node dysfunction ranging from benign to severe

  • Discontinuing lithium is the key to improving bradycardia in these patients, some patients will require a permanent pacemaker to decrease symptoms upon resumption of lithium therapy [1]

Read more

Summary

A Rare but Reversible Cause of Lithium-Induced Bradycardia

Basma Ataallah 1, 2 , Rana Al-Zakhari 3 , Aman Sharma 1 , Michael Tofano 4 , Gregory Haggerty 5, 1. 1. Internal Medicine, Zucker School of Medicine at Mather, Port Jefferson, USA 2. Medicine/Cardiology, Northwell Health Mather Hospital, Port Jefferson, USA 5. Graduate Medical Education, Northwell Health Mather Hospital, Port Jefferson, USA

Introduction
Discussion
Conclusions
Disclosures
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.